| SOLVONIS THERAPEUTICS PLC |
| Großbritannien |
| Gesundheit |
| GB00BMD1Z199 / A3DCC0 |
| J4I (Frankfurt) |
| FRA:J4I, ETR:J4I, J4I:GR |
| - |
| https://solvonis.com/ |
|
Solvonis Therapeutics plc is a clinical-stage biopharmaceutical company dedicated to developing novel medicines for addiction and mental health disorders, targeting high-burden neuropsychiatric conditions with significant unmet needs. Headquartered i..
>Volltext.. |
| 18.71 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| SOLVONIS |
| 05.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|